Current Hematologic Malignancy Reports

Papers
(The TQCC of Current Hematologic Malignancy Reports is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations78
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions36
Monoclonal Gammopathy-Associated Neuropathy26
Management of Chronic Myeloid Leukemia in Children and Young Adults22
Telomere Biology Disorder: A Focus on Gastrointestinal and Hepatic Manifestations22
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications17
Correction to: Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities17
Contemporary Updates in the Prevention and Treatment of Graft-Versus-Host Disease17
Challenges in Chronic Myeloid Leukemia Management in South America14
Treatment-Free Remission: the New Goal in CML Therapy13
Transplantation and Cellular Therapy for Older Adults—The MSK Approach12
Value in Myeloma Care: Myth or Reality12
Targeting Apoptosis in ALL12
Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer12
Acute Lymphoblastic Leukemia and Acute Lymphoblastic Lymphoma: Same Disease Spectrum but Two Distinct Diagnoses11
Philadelphia-Negative Myeloproliferative Neoplasms Around the COVID-19 Pandemic11
Prognostic and Predictive Models in Myelofibrosis11
Multidisciplinary Approach to Older Adults with Hematologic Malignancies—a Paradigm Shift11
New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications10
How Do We Manage Chronic Lymphocytic Leukemia in India10
Diagnosis and Management of Pulmonary Manifestations of Telomere Biology Disorders10
Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies10
Multiple Myeloma: Current Clinical Landscape and Compounding Costs9
The Evolving Landscape of Frontline Therapy in Chronic Phase Chronic Myeloid Leukemia (CML)9
Health-Related Quality of Life of Patients with Chronic Myeloid Leukemia as Measured by Patient-Reported Outcomes: Current State and Future Directions8
Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults8
Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia8
Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia8
A Multi-disciplinary Approach to Managing Chronic Myelogenous Leukemia Patients on Oral Anticancer Therapy at a Large Academic Medical Center7
Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies7
Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders7
Family Planning and Pregnancy in Patients with Chronic Myeloid Leukemia7
Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies7
0.029927015304565